Quince Therapeutics, Inc. - ROE
QNCX
Price:
$0.9451
Market Cap:
$5.26M
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 20...[Read more]
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
QNCX
PE Ratio
[-0.09]
ROE
[1.82%]
Current Ratio
[2.92]
Dividend Yield
[0%]
Enterprise Value
[-12494541.00]
Dividend History
The ROE as of June 2026 (TTM) for Quince Therapeutics, Inc. (QNCX) is 1.82%
According to Quince Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.82%. This represents a change of -783.96% compared to the average of -266.61% of the last 4 quarters.
Quince Therapeutics, Inc. (QNCX) Historical ROE (quarterly & annually)
How has QNCX ROE performed in the past?
The mean historical ROE of Quince Therapeutics, Inc. over the last ten years is -16.80%. The current 1.82% ROE has changed -10951.96% with respect to the historical average. Over the past ten years (40 quarters), QNCX's ROE was at its highest in in the March 2026 quarter at 229.15%. The ROE was at its lowest in in the September 2025 quarter at -1269.31%.
Average
-16.80%
Median
-36.89%
Minimum
-188.51%
Maximum
235.14%
Quince Therapeutics, Inc. (QNCX) ROE by Quarter and Year
Discovering the peaks and valleys of Quince Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 411.04%
Maximum Annual ROE = 235.14%
Minimum Annual Increase = -224.74%
Minimum Annual ROE = -188.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | 235.14% | -224.74% |
| 2024 | -188.51% | 411.04% |
| 2023 | -36.89% | -28.17% |
| 2022 | -51.36% | -32.29% |
| 2021 | -75.85% | 70.02% |
| 2020 | -44.61% | 39.31% |
| 2019 | -32.02% | 83.32% |
| 2018 | -17.47% | -128.95% |
Quince Therapeutics, Inc. (QNCX) Average ROE
How has QNCX ROE performed in the past?
The current ROE of Quince Therapeutics, Inc. (QNCX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.25%
5-year avg
-23.49%
10-year avg
-16.80%
Quince Therapeutics, Inc. (QNCX) ROE vs. Peers
How is QNCX’s ROE compared to its peers?
Quince Therapeutics, Inc.’s ROE is greater than aTyr Pharma, Inc. (-99.87%), greater than Precision BioSciences, Inc. (-81.24%), greater than InflaRx N.V. (-94.90%), greater than Metagenomi, Inc. Common Stock (-51.23%), greater than Fractyl Health, Inc. Common Stock (-4573.89%), greater than ALX Oncology Holdings Inc. (-124.06%), greater than Connect Biopharma Holdings Limited (-49.43%), greater than Adverum Biotechnologies, Inc. (-3844.85%), greater than CAMP4 Therapeutics Corporation (-194.74%), greater than Kalaris Therapeutics Inc (-72.78%),
| Company | ROE | Market cap |
|---|---|---|
| -99.87% | $44.17M | |
| -81.24% | $87.36M | |
| -94.90% | $130.74M | |
| -51.23% | $45.18M | |
| -4573.89% | $61.96M | |
| -124.06% | $205.88M | |
| -49.43% | $125.93M | |
| -3844.85% | $96.26M | |
| -194.74% | $87.72M | |
| -72.78% | $88.28M |
Build a custom stock screener for Quince Therapeutics, Inc. (QNCX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quince Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Quince Therapeutics, Inc. (QNCX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Quince Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Quince Therapeutics, Inc.'s ROE?
How is the ROE calculated for Quince Therapeutics, Inc. (QNCX)?
What is the highest ROE for Quince Therapeutics, Inc. (QNCX)?
What is the 3-year average ROE for Quince Therapeutics, Inc. (QNCX)?
What is the 5-year average ROE for Quince Therapeutics, Inc. (QNCX)?
How does the current ROE for Quince Therapeutics, Inc. (QNCX) compare to its historical average?